DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 8,338.416 B2 Buggy Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 8,338.416 B2 Buggy Et Al USOO8338416B2 (12) United States Patent (10) Patent No.: US 8,338.416 B2 Buggy et al. (45) Date of Patent: Dec. 25, 2012 (54) INDOLE DERIVATIVES AS INHIBITORS OF WO WO2007/048841 * 5/2007 HISTONE DEACETYLASE WO WO2O08060721 * 5/2008 WO WO 2008061160 * 5/2008 (75) Inventors: Joseph J. Buggy, Mountain View, CA OTHER PUBLICATIONS (US); Sriram Balasubramanian, San & 8 18 Carlos, CA (US); Erik Verner, San Chawla et al., "Challenges in Polymorphism of Pharmaceuticals'. Mateo, CA (US); Vincent W. F. Tai, San CRIPS vol. 5 Nolan-Mar 2004 ("Pages"." Mateo, CA (US); Chang-Sun Lee, Belle Newman et al., “Solid-state analysis of the active pharmaceutical s s s ingredient in drug products'. DDT vol. 8, No. 19, Oct. 2003, p. Mead, NJ (US) 898-905. Bhalla, K.N., “Epigenetic and Chromatin Modifiers as Targeted (73) Assignee: Pharmacylics, Inc., Sunnyvale, CA Therapy of Hematologic Malignancies,” J. Clin. Oncol. 23:3971 (US) 3993 (2005). Buggy et al., “Cloning and characteristics of a novel human histone (*) Notice: Subject to any disclaimer, the term of this deacetylase, HDAC8.” Biochem. J. 350 Pt. 1: 199-205 (2000). patent is extended or adjusted under 35 Carta et al., “Histone deacetylase inhibitors prevent exocytosis of U.S.C. 154(b) by 581 days. interleukin-13-containing Secretory lysosomes: role of microtubules.” Blood 108(5):1618-1626 (2006). (21) Appl. No.: 11/687.565 Fuino, L. et al., "Histone deacetylase inhibitor LAQ824 down-regu lates Her-2 and sensitizes human breast cancer cells to trastuzumab, (22) Filed: Mar 16, 2007 536 smiline and epothilone B.” Mol. Cancer Ther. 2:971 Jacobs et al., “Substituted 3-(Phenylmethyl)-1 H-indole-5- (65) Prior Publication Data carboxamides and 1-(Phenylmethyl)indole-6-carboxamides as US 2007/O28 1934 A1 Dec. 6, 2007 Potent, Selective, Orally Active Antagonists of the Peptidoleukotrienes.” J. Med. Chem. 36:394-409 (1993). Related U.S. Application Data Leoni et al., “The antitumor histone deacetylase inhibitor Suberoylanilide hydroxamic acid exhibits antiinflammatory proper (60) Provisional application No. 60/783.287, filed on Mar. ties via supression of cytokines.” PNAS USA99:2995-3000 (2002). 16, 2006. Miller et al., “Histone deacetylase inhibitors.” J. Med. Chem. 46(24):5097-5116 (2003). (51) Int. Cl. Somoza et al., “Structural Snapshots of Human HDAC8 Provide CO7D 40/02 (2006.01) Insights into the Class 1 Histone Deacytelases.” Structure 12:1325 CO7D 209/04 (2006.01) 1334 (2004). CO7D 413/02 (2006.01) Vannini et al., “Crystal structure of a eukaryotic zinc-dependent histone deacytelase, human HDAC8, complexed with a hydroxamic A6 IK3I/404 (2006.01) acid inhibitor.” PNAS 101(42): 15064-15069 (2004). A6 IK3 L/4523 (2006.01) Yoo, C.B. and Jones, P.A., “Epigenetic therapy of cancer: past, A 6LX3/5377 (2006.01) present and future.” Nat. Rev. Drug Discov. 5:37-50 (2006). A6IP35/00 (2006.01) PCT/US07/06714 Search Report dated May 27, 2008. A6IP35/02 (2006.01) (52) U.S. Cl. ..................... 514/235.2: 514/320: 514/415; * cited by examiner 544/143: 546/201: 548/452 (58) Field of Classification Search ........................ None Primary Examiner — Sun Jae Loewe See application file for complete search history. X: terney, Agent, or Firm — Wilson, Sonsini, Goodrich OSa1 (56) References Cited (57) ABSTRACT U.S. PATENT DOCUMENTS Described herein are compounds and pharmaceutical com 6,069,156 A 5, 2000 Oku et al. positions containing such compounds, which inhibit the 6,303,600 B1 10/2001 Cox et al. activity of histone deacetylase 8 (HDAC8). Also described 200 SE R 258 East al. herein are methods of using such HDAC8 inhibitors, alone 2008/01 12889 A1* 5/2008 Buggy et also 424.9.2 and in combination with other compounds, for treating dis eases or conditions that would benefit from inhibition of FOREIGN PATENT DOCUMENTS HDAC8 activity. WO WO-02-055O17 T 2002 WO WO-2003-013493 2, 2003 19 Claims, 18 Drawing Sheets U.S. Patent Dec. 25, 2012 Sheet 1 of 18 US 8,338.416 B2 Fig. 1A Representative tissue samples Brain Breast 1374019: Neurons and Glia 1374021: Duct 40X 40X Kidney 1374023: Mucosa 40X 1374027: Glomerulus 40X Liver 1374033: Portal Triad and : XXa Hepatocytes 40X 1374036: Bronchiole 40X ovary Pancreas & SS 1374043: Follicles and Stroma 40X 1374172: Adjacent Residual Islet 40X U.S. Patent Dec. 25, 2012 Sheet 2 of 18 US 8,338.416 B2 Fig. 1B Representative tissue samples Prostate Skel Muscle 1374050: Glandular Epithelium and Stroma 40X Skin 1374053: Squamous 1374055: Villi 40X Epithelium 40X Spleen Stomach 1374068: Muscularis 1374059: Red Pulp 40X P ropriaia 40X & 1374158: Epithelium and Lymphocytes 40X U.S. Patent Dec. 25, 2012 Sheet 3 of 18 US 8,338.416 B2 Fig. 2 HDAC8 in islet DELTA cells HDAC8 Ab 1 HDAC8 HDAC8 insulin :-SS & S & 1370559: HDAC8-Celera, 1370562: HDAC8-Celera + insulin, set 40X Set 40X HDAC8 Somatostatin RS ' ' 1370567 HDAC8-Celera - 1370626 HDAC8-Celera - Glucagon, Islet 40X Somatostatin, Islet 40X HDAC8 Ab #2 HDAC8 HDAC8 insulin 137O608 HDAC8 SC 11405, Islet 40X 137O611. HDAC8-SC-11405 - Insulin, Islet 40X HDAC8+ glucagon HDAC8 + somatostatin 137O614 HDACB-SC-11405 1370617: HDAC8-SC-11405 + Glucagon, Islet 40X Somatostatin, Islet 40X U.S. Patent Dec. 25, 2012 Sheet 4 of 18 US 8,338.416 B2 Fig. 3 HDAC8 in plasma cells 1374430: Malignant Cells 1374431: Lymphocytes and 40X Plasma Cells 60X S. S XSS & S & 1374159: Lymphocytes 40X 1374.325: Cardiac Myocytes 1374326: Plasma Cells 6OX 40X 'S "S 1374460: Malignant Cells 40X 1374461: Plasma CellS 6OX U.S. Patent Dec. 25, 2012 Sheet 5 of 18 US 8,338.416 B2 Fig. 4 HDAC8 protein is found in tumor cell line Ramos Raji DHL-4 Jurkat HuT78 DB K562 HDAC8 HSC 70 o A549 HCT-116 MCF-7 OVCR-3 PC3 RKO U87 K562 Jurkat HDAC8 HSC 70 U.S. Patent Dec. 25, 2012 Sheet 6 of 18 US 8,338.416 B2 Fig. 5 HDAC8 protein expression is modulated in a dose-dependent manner by both compound 23 and the pan-HDAC inhibitor PCI-24781 Compound 23 (uM) PCI-24781 (uM) Control 1 5 25 0.04 0.2 1 U.S. Patent Dec. 25, 2012 Sheet 7 of 18 US 8,338.416 B2 Fig. 6 HDAC8 knockdown leads to apoptosis Untreated SCrambled Á??A??oeasedseopaz||euuuoN ©Ns= ee U.S. Patent Dec. 25, 2012 Sheet 8 of 18 US 8,338.416 B2 Fig. 7 Apoptosis induced by compound 23 is blocked by a pan-Caspase inhibitor Annexin VIPl: Jurkat PCI-34051 CD 2 5 O Annexin V O n s O SS Control 10M qVD-OPh Compound 23 Compound 23 (5uM) (5uM) + 1 OuMcVD-OPh Treatment U.S. Patent Dec. 25, 2012 Sheet 9 of 18 US 8,338.416 B2 Fig. 8 Compound 23 does not inhibit growth of Selected Solid tumor lines F33 - A1, OVCAR-3, A Pa Ca-2, PANC is 8:338. 33333.3-liki 388x *.si $33, 33.38 Si Esi E::s: U.S. Patent Dec. 25, 2012 Sheet 10 of 18 US 8,338.416 B2 Fig. 9 Compound 23 Does Not Inhibit Growth Of HCT116 Or Human PBMCS HCT-11648-hr Alamar Blue Assay 120 ---.24781 ... S. 23 s d B L O -H O.O1 0.1 1 10 1OO Concentration (uM) PBMC 24-hr Alamar Blue Assay 140 12O 100 3 80 3 60 9 40 --24781 2O ... &. 23 O - O.O1 O.1 1 10 1OO Concentration (uM) U.S. Patent Dec. 25, 2012 Sheet 11 of 18 US 8,338.416 B2 Fig. 10 Compound 23 is cytotoxic to T-cell derived tumor cells ... T-Cell derived Cell lines -- B-Cell derived Cell lines Jurkat (Glso = 3 uM) DB (Glso >20 uM) HuT78 (Glso = 4 uM) K562 (Go 220 uM) 8/8 Solid tumor lines 4.O - Human normal PBMCs (24 hrs) Š d 3. O C Control 2 s Comp23 g 20 al x 1 O g U.S. Patent Dec. 25, 2012 Sheet 12 of 18 US 8,338.416 B2 Fig.11 Inhibition of IL-1b secretion in human PBMCs Dexamethasone & Compound 23 GSS Ne1 C ...O C C 1E-05 1E-04 1E-03 1E-02 1E-O1 1E-OO 1E--O1 Concentration (uM) U.S. Patent Dec. 25, 2012 Sheet 13 of 18 US 8,338.416 B2 Fig. 12 Compound 23 inhibits IL-1 b secretion in THP-1 monocyte cell line Effect of LPS and compound 23 on IL-1B secretion in THP-1 cells normalized to control DMSO+LPS O.5uMH-LPS 5.OUM-LPS Treatment, 24 hrs U.S. Patent Dec. 25, 2012 Sheet 14 of 18 US 8,338.416 B2 Fig. 13 Phospholipase C-gamma 1-deficient Jurkat derivative J.gamma1 cells are resistant to Compound 23-induced apoptosis but TCR signaling mutants are not 1 O O SS se Control 2 s 8 O CD compound 23 c e 6 O O ? 4 O e s& S S S X d 2 O SS e O S.S S & U.S. Patent Dec. 25, 2012 Sheet 15 of 18 US 8,338.416 B2 Fig. 14 Phospholipase inhibitor modulates compound 23-induced apoptosis 6 O Ss I d5 O c) 4 O 2 t O n 2 S X C) C C C O 0.8 0.1 0.2 0.4 0.8 0.1 0.2 0.4 U-73343 U-73122 (uM) U-73343 U-73122 (uM) (uM) (uM) Control Compound 23 (10uM) U.S. Patent Dec. 25, 2012 Sheet 16 of 18 US 8,338.416 B2 Fig. 15 Compound 23 induced apoptosis is enhanced by Ca2+ effector thapsigargin 35 in Jurkat cells but not in J.gamma cells 122 5O5 1 O Control Compound 23 thapsigargin Compound 23 + thapsigargin U.S.
Load more

Recommended publications
  • Replacement Therapy, Not Recreational Tonic Testosterone, Widely Used As a Lifestyle Drug, Is a Medicine and Should Be Kept As Such
    correspondence Replacement therapy, not recreational tonic Testosterone, widely used as a lifestyle drug, is a medicine and should be kept as such. Sir — We read with great interest the News male tonics and remedies — most harmless, your Feature that there is a need for large- Feature “A dangerous elixir?” (Nature 431, but some as drastic as grafting goat testicles scale, long-term clinical trials to address 500–501; 2004) reporting the zeal with onto humans. Unfortunately, a certain several issues associated with testosterone which testosterone is being requested by amount of quackery is now perceived to be use. For example, testosterone therapy may men who apparently view the hormone as associated with testosterone therapy, and the be beneficial against osteoporosis, heart a ‘natural’ alternative to the drug Viagra. increased prescription of the hormone in disease and Alzheimer’s disease, but the Like Viagra, testosterone replacement recent years does little to dispel this notion. dangers remain obscure. therapy — with emphasis on the word Nonetheless, as your Feature highlights, Until we know more, both prescribing ‘replacement’ — is a solution to a very real hypogonadism is a very real clinical clinicians and the male population need to clinical problem. There is a distinction condition. It is characterized by abnormally be aware that testosterone, like any other between patients whose testosterone has low serum levels of testosterone, in medication, should only be administered declined to abnormally low levels, and conjunction with symptoms such as to patients for whom such therapy is individuals seeking testosterone as a pick- mood disturbance, depression, sexual clinically indicated. me-up.
    [Show full text]
  • DDT and Its Derivatives Have Remained in the Environment
    International Journal of Molecular Sciences Review A Novel Action of Endocrine-Disrupting Chemicals on Wildlife; DDT and Its Derivatives Have Remained in the Environment Ayami Matsushima Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Fukuoka 819-0395, Japan; [email protected]; Tel.: +81-92-802-4159 Received: 20 March 2018; Accepted: 2 May 2018; Published: 5 May 2018 Abstract: Huge numbers of chemicals are released uncontrolled into the environment and some of these chemicals induce unwanted biological effects, both on wildlife and humans. One class of these chemicals are endocrine-disrupting chemicals (EDCs), which are released even though EDCs can affect not only the functions of steroid hormones but also of various signaling molecules, including any ligand-mediated signal transduction pathways. Dichlorodiphenyltrichloroethane (DDT), a pesticide that is already banned, is one of the best-publicized EDCs and its metabolites have been considered to cause adverse effects on wildlife, even though the exact molecular mechanisms of the abnormalities it causes still remain obscure. Recently, an industrial raw material, bisphenol A (BPA), has attracted worldwide attention as an EDC because it induces developmental abnormalities even at low-dose exposures. DDT and BPA derivatives have structural similarities in their chemical features. In this short review, unclear points on the molecular mechanisms of adverse effects of DDT found on alligators are summarized from data in the literature, and recent experimental and molecular research on BPA derivatives is investigated to introduce novel perspectives on BPA derivatives. Especially, a recently developed BPA derivative, bisphenol C (BPC), is structurally similar to a DDT derivative called dichlorodiphenyldichloroethylene (DDE).
    [Show full text]
  • Pesticides Reduce Symbiotic Efficiency of Nitrogen-Fixing Rhizobia and Host Plants
    Pesticides reduce symbiotic efficiency of nitrogen-fixing rhizobia and host plants Jennifer E. Fox*†, Jay Gulledge‡, Erika Engelhaupt§, Matthew E. Burow†¶, and John A. McLachlan†ʈ *Center for Ecology and Evolutionary Biology, University of Oregon, 335 Pacific Hall, Eugene, OR 97403; †Center for Bioenvironmental Research, Environmental Endocrinology Laboratory, Tulane University, 1430 Tulane Avenue, New Orleans, LA 70112-2699; ‡Department of Biology, University of Louisville, Louisville, KY 40292 ; §University of Colorado, Boulder, CO 80309; and ¶Department of Medicine and Surgery, Hematology and Medical Oncology Section, Tulane University Medical School, 1430 Tulane Avenue, New Orleans, LA 70112-2699 Edited by Christopher B. Field, Carnegie Institution of Washington, Stanford, CA, and approved May 8, 2007 (received for review January 8, 2007) Unprecedented agricultural intensification and increased crop by plants, in rotation with non-N-fixing crops (8, 15). The yield will be necessary to feed the burgeoning world population, effectiveness of this strategy relies on maximizing symbiotic N whose global food demand is projected to double in the next 50 fixation (SNF) and plant yield to resupply organic and inorganic years. Although grain production has doubled in the past four N and nutrients to the soil. The vast majority of biologically fixed decades, largely because of the widespread use of synthetic N is attributable to symbioses between leguminous plants (soy- nitrogenous fertilizers, pesticides, and irrigation promoted by the bean, alfalfa, etc.) and species of Rhizobium bacteria; replacing ‘‘Green Revolution,’’ this rate of increased agricultural output is this natural fertilizer source with synthetic N fertilizer would cost unsustainable because of declining crop yields and environmental Ϸ$10 billion annually (16, 17).
    [Show full text]
  • Past Use of Chlordane, Dieldrin, And
    The Hazard Evaluation and Emergency Response Office (HEER Office) is part of the Hawai‘i Department of Health (HDOH) Environmental Health Administration, whose mission is to protect human health and the environment. The HEER Office provides leadership, support, and partnership in preventing, planning for, responding to, and enforcing environmental laws relating to releases or threats of releases of hazardous substances. Past Use of Chlordane, Dieldrin, and other Organochlorine Pesticides for Termite Control in Hawai‘i: Safe Management Practices around Treated Foundations or during Building Demolition This fact sheet provides building owners, demolition and construction contractors, developers, realtors, and others with an overview of the potential environmental concerns associated with the past use of organochlorine termiticides (pesticides used to control termites) in Hawai‘i. In addition, this fact sheet discusses methods for reducing exposure to organochlorine termiticides during building demolition or around the foundations of treated buildings and identifies resources for further information. What are organochlorine termiticides? Organochlorine termiticides are a group of pesticides that were used for termite control in and around wooden buildings and homes from the mid-1940s to the late 1980s. These organochlorine pesticides included chlordane, aldrin, dieldrin, heptachlor, and dichlorodiphenyltrichloroethane (DDT). They were used primarily by pest control operators in Hawaii’s urban areas, but also by homeowners, the military, the state, and counties to protect buildings against termite damage. In the 1970s and 1980s, the U.S. Environmental Protection Agency (EPA) banned all uses of these organochlorine pesticides except for heptachlor, which can be used today only for control of fire ants in underground power transformers.
    [Show full text]
  • A General-Purpose Garden Pesticide C
    West Virginia Agricultural and Forestry Experiment Davis College of Agriculture, Natural Resources Station Bulletins And Design 1-1-1954 A general-purpose garden pesticide C. K. Dorsey M. E. Gallegly Follow this and additional works at: https://researchrepository.wvu.edu/ wv_agricultural_and_forestry_experiment_station_bulletins Digital Commons Citation Dorsey, C. K. and Gallegly, M. E., "A general-purpose garden pesticide" (1954). West Virginia Agricultural and Forestry Experiment Station Bulletins. 365T. https://researchrepository.wvu.edu/wv_agricultural_and_forestry_experiment_station_bulletins/630 This Bulletin is brought to you for free and open access by the Davis College of Agriculture, Natural Resources And Design at The Research Repository @ WVU. It has been accepted for inclusion in West Virginia Agricultural and Forestry Experiment Station Bulletins by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. BULLETIN 365T June 1954 WEST VIRGINIA UNIVERSITY AGRICULTURAL EXPERIMENT STATION AUTHORS Authors of A General-Purpose Garden Pesti- cide are C. K. DORSEY, Entomologist and Professor of Entomology, and M. E. GAL- LEGLY, Assistant Plant Pathologist and As- sistant Professor of Plant Pathology. ACKNOWLEDGEMENT The authors are indebted to Kemper L. Callahan for assistance in portions of the studies. West Virginia University Agricultural Experiment Station College of Agriculture, Forestry, and Home Economics H. R. Varney, Director MORGANTOWN A General-Purpose Garden Pesticide C. K. DORSEY and M. E. GALLEGLY IN recent years numerous new insecticides and fungicides have been developed and many have been recommended for use in the home garden. These vary considerably in their effectiveness in the control of different pests. For example, rotenone is effective in controlling the Mexican bean beetle and the potato flea beetle, but is ineffective against the potato leafhopper.
    [Show full text]
  • Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer
    International Journal of Molecular Sciences Review Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer Louisane Eve 1,2,3,4,Béatrice Fervers 5,6, Muriel Le Romancer 2,3,4,* and Nelly Etienne-Selloum 1,7,8,* 1 Faculté de Pharmacie, Université de Strasbourg, F-67000 Strasbourg, France; [email protected] 2 Université Claude Bernard Lyon 1, F-69000 Lyon, France 3 Inserm U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France 4 CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France 5 Centre de Lutte Contre le Cancer Léon-Bérard, F-69000 Lyon, France; [email protected] 6 Inserm UA08, Radiations, Défense, Santé, Environnement, Center Léon Bérard, F-69000 Lyon, France 7 Service de Pharmacie, Institut de Cancérologie Strasbourg Europe, F-67000 Strasbourg, France 8 CNRS UMR7021/Unistra, Laboratoire de Bioimagerie et Pathologies, Faculté de Pharmacie, Université de Strasbourg, F-67000 Strasbourg, France * Correspondence: [email protected] (M.L.R.); [email protected] (N.E.-S.); Tel.: +33-4-(78)-78-28-22 (M.L.R.); +33-3-(68)-85-43-28 (N.E.-S.) Received: 27 October 2020; Accepted: 25 November 2020; Published: 30 November 2020 Abstract: Breast cancer (BC) is the second most common cancer and the fifth deadliest in the world. Exposure to endocrine disrupting pollutants has been suggested to contribute to the increase in disease incidence. Indeed, a growing number of researchershave investigated the effects of widely used environmental chemicals with endocrine disrupting properties on BC development in experimental (in vitro and animal models) and epidemiological studies.
    [Show full text]
  • The Five W's of Edcs
    THE FIVE W’s oF EDCs Endocrine disrupting chemicals, or EDCs, are substances in the environment (air, soil, or water supply), food and beverages, and manufactured products WHAT that can interfere with the normal functioning of our body’s endocrine system. are EDCs? Many of their effects on humans are still unknown and require more research. The endocrine system controls the way your body develops and functions. It produces hormones that travel to all parts of your body ( to maintain your tissues and organs, and to participate in overall health. ) Visit hormone.org for more information. EDCs are found in everyday household products. As of October 2013, there are nearly 1,000 chemicals on The Endocrine Disruption Exchange (TEDX) WHY list: endocrinedisruption.org. should I be These chemicals are found in: concerned • Contaminated soil, water and air • Common household items: • Food contaminated through plastics, household chemicals, about EDCs? chemicals in the food chain toys, flame-retardant fabrics, • Food packaging: lining of cans, cosmetics, medications, plastic antibacterial soaps • Workplace: industrial chemicals, pesticides, fungicides Plastics Industrial solvents/lubricants Pesticides Bisphenol A (BPA), Polychlorinated biphenyls Dichlorodiphenyltrichloro- phthalates (PCBs), dioxins ethane (DDT), methoxychlor, chlorpyrifos Fungicides Herbicides Antibacterials Vinclozolin Atrazine Triclosan Personal care products Textiles, clothing Children’s products Phthalates Perfluorochemicals Lead, phthalates, (PFCs) cadmium Advocate for more research and improved federal regulations by contacting members of Congress: endocrine.org/advocacy-and-outreach/take-action/contact-congress WHERE WHEN do EDCs do the impact effects my body? take shape? More research is Endocrine, needed, but we reproductive and/ know EDCs affect: or neurological problems occur more frequently in Response to stress humans with higher • Neurological and [female] amounts of EDCs in behavioral changes their bodies.
    [Show full text]
  • What Do We Know About Ddt? How Does Ddt Affect Human
    October 2016 DDT (DICHLORODIPHENYLTRICHLOROETHANE) ENVIRONMENTAL HEALTH – CONTAMINANTS FACT SHEETS WHAT DO WE KNOW ABOUT DDT? DDT is a persistent organic pollutant (POP). It is made by POPs (such as DDT) can build up in animal tissues humans and does not occur naturally in the environment. over time through a process called bioaccumulation DDT was used as an insecticide to prevent the spread of (see Contaminants Overview fact sheet – disease and to protect crops. Canada banned the use of DDT http://www.hss.gov.nt.ca). This means that older animals in the 1980s, but some countries (primarily in Africa) still tend to have higher levels of POPs than younger animals. use it to prevent the spread of diseases, like malaria, that POPs tend to be found at higher levels in animals that eat are carried by insects. other animals and in smaller amounts in animals that eat plants. This is due to a process called biomagnification DDT is a mixture of several similar chemicals. It is very (see Contaminants Overview fact sheet – stable and lasts a long time in the environment. It can http://www.hss.gov.nt.ca). Marine mammals tend to travel long distances in the air and settle in regions far have the highest levels of POPs. away from where it came. This process is called Long Range Atmospheric Transport (see Contaminants Overview fact POPs do not dissolve very well in water. When POPs enter sheet - http://www.hss.gov.nt.ca). water, they will stick to sediments instead. This means that water contains very low levels of POPs and we do not need to be concerned about POPs in the water.
    [Show full text]
  • What Is DDT? • DDT 1 Is an Organochlorine2 Insecticide That Was First Synthesized in 1874 (1,2)
    This fact sheet was created in 1999; some of the information may be out-of-date. NPIC is not planning to update this fact sheet. More pesticide fact sheets are available here. Please call NPIC with any questions you have about pesticides at 800- 858-7378, Monday through Friday, 7:30 am to 3:30 am PST. NPTN General Fact Sheets are designed to answer questions that are commonly asked by the general public about pesticides that are regulated by the U.S. Environmental Protection Agency (US EPA). This document is intended to be educational in nature and helpful to consumers for making decisions about pesticide use. DDT (General Fact Sheet) For more technical information, please refer to the Technical Fact Sheet The Pesticide Label: Labels provide directions for the proper use of a pesticide product. Be sure to read the entire label before using any product. A signal word, on each product label, indicates the product’s short-term toxicity. CAUTION - low toxicity WARNING - moderate toxicity DANGER - high toxicity What is DDT? • DDT 1 is an organochlorine2 insecticide that was first synthesized in 1874 (1,2). • DDT was a commonly-used pesticide for insect control in the United States until it was canceled in 1972 by the United States Environmental Protection Agency (EPA). Why was DDT used? • DDT was initially used by the military in WW II to control malaria, typhus, body lice, and bubonic plague (1). Cases of malaria fell from 400,000 in 1946 to virtually none in 1950 (3). DDT is still used today in South America, Africa, and Asia for this purpose.
    [Show full text]
  • Toxicity of DDT, Dieldrin, Malathion and Fenthion to Rhodnius Prolixus in the Laboratory * by IRVING Fox and ILEANA G
    974 NOTES Toxicity of DDT, Dieldrin, Malathion and Fenthion to Rhodnius prolixus in the Laboratory * by IRVING Fox and ILEANA G. BAYONA, School of Tropical Medicine, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico, and HELDA ISABEL OROZCO, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia Extensive published data on Rhodnius prolixus 11 first-stage and second-stage nymphs brought to cover its distribution and epidemiological role in the School of Tropical Medicine, San Juan, Puerto Chagas' disease in Venezuela," extradomiciliary Rico, by one of us (H.I.O.) on 18 May 1962. These habits,b resistance to practical chemical control specimens originated from a colony in the Facultad efforts,c insect parasites,d life-cycle in the labor- de Medicina, Universidad de Antioquia, Medellin, atory,e, f, ' and effects of radiation on reproduc- Colombia. Concerning this colony, Dr Marcos tion.h, In marked contrast there is a lack of Restrepo I. wrote as follows, in a letter dated toxicological knowledge as derived from laboratory 18 January 1966: tests developed by Busvine & LienJ and by the The strain of Rhodnius prolixus we have in our depart- WHO Expert Committee on Insecticides." It is ment was provided out of one established in BogotA important to obtain this kind of information about from specimens found in various parts of the country, different strains of this serious pest because some especially in the Western Llanos of Colombia and the experts, in their master plans for the control of Department of North Santander. The colony has been Chagas' disease, have contemplated the widespread established for some years (more than 10).
    [Show full text]
  • Ddt in Indoor Residual Spraying: Human Health Aspects
    Environmental Health Criteria 241 DDT IN INDOOR RESIDUAL SPRAYING: HUMAN HEALTH ASPECTS The International Programme on Chemical Safety (IPCS) was established in 1980. The overall objectives of the IPCS are to establish the scientific basis for assessment of the risk to human health and the environment from exposure to chemicals, through international peer review processes, as a prerequisite for the promotion of chemical safety, and to provide technical assistance in strengthening national capacities for the sound management of chemicals. This publication was developed in the IOMC context. The contents do not necessarily reflect the views or stated policies of individual IOMC Participating Organizations. The Inter-Organization Programme for the Sound Management of Chemicals (IOMC) was established in 1995 following recommendations made by the 1992 UN Conference on Environment and Development to strengthen cooperation and increase international coordination in the field of chemical safety. The Participating Organizations are FAO, ILO, UNEP, UNIDO, UNITAR, WHO, World Bank and OECD. UNDP is an Observer. The purpose of the IOMC is to promote coordination of the policies and activities pursued by the Participating Organizations, jointly or separately, to achieve the sound management of chemicals in relation to human health and the environment. WHO Library Cataloguing-in-Publication Data DDT in indoor residual spraying: human health aspects. (Environmental health criteria ; 241) 1.DDT - adverse effects. 2.Pesticide residues - toxicity. 3.Air pollution, Indoor. 4.Risk assessment. I.World Health Organization. ISBN 978 92 4 157241 5 (NLM classification: WA 240) ISSN 0250-863X © World Health Organization 2011 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]).
    [Show full text]
  • A Textbook of Clinical Pharmacology and Therapeutics This Page Intentionally Left Blank a Textbook of Clinical Pharmacology and Therapeutics
    A Textbook of Clinical Pharmacology and Therapeutics This page intentionally left blank A Textbook of Clinical Pharmacology and Therapeutics FIFTH EDITION JAMES M RITTER MA DPHIL FRCP FMedSci FBPHARMACOLS Professor of Clinical Pharmacology at King’s College London School of Medicine, Guy’s, King’s and St Thomas’ Hospitals, London, UK LIONEL D LEWIS MA MB BCH MD FRCP Professor of Medicine, Pharmacology and Toxicology at Dartmouth Medical School and the Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA TIMOTHY GK MANT BSC FFPM FRCP Senior Medical Advisor, Quintiles, Guy's Drug Research Unit, and Visiting Professor at King’s College London School of Medicine, Guy’s, King’s and St Thomas’ Hospitals, London, UK ALBERT FERRO PHD FRCP FBPHARMACOLS Reader in Clinical Pharmacology and Honorary Consultant Physician at King’s College London School of Medicine, Guy’s, King’s and St Thomas’ Hospitals, London, UK PART OF HACHETTE LIVRE UK First published in Great Britain in 1981 Second edition 1986 Third edition 1995 Fourth edition 1999 This fifth edition published in Great Britain in 2008 by Hodder Arnold, an imprint of Hodden Education, part of Hachette Livre UK, 338 Euston Road, London NW1 3BH http://www.hoddereducation.com ©2008 James M Ritter, Lionel D Lewis, Timothy GK Mant and Albert Ferro All rights reserved. Apart from any use permitted under UK copyright law, this publication may only be reproduced, stored or transmitted, in any form, or by any means with prior permission in writing of the publishers or in the case of reprographic production in accordance with the terms of licences issued by the Copyright Licensing Agency.
    [Show full text]